Effects of a "Walk, Eat, & Breathe" Nursing Intervention For Patients With Esophageal Cancer
1 other identifier
interventional
144
1 country
1
Brief Summary
The purpose of this stratified randomized controlled trial (RCT) is to test the effects of Walk, Eat, \& Breathe on preserving patients' nutritional status, functional walking capacity, pulmonary function, and emotional well-being during the CCRT and surgery course.Additionally, effects to reduce treatment-related complications and length of hospital stay for esophagectomy will be evaluated between experimental and control groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 11, 2016
CompletedFirst Posted
Study publicly available on registry
July 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedSeptember 26, 2017
September 1, 2017
2.9 years
May 11, 2016
September 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Body weight
Record the trajectory of body weight during cancer treatment
5 months
Lean muscle mass
Record the trajectory of lean muscle mass during cancer treatment using bioelectrical impedance analysis
5 months
functional walking capacity
Record the trajectory of walking capacity during cancer treatment using 6-min walk test
5 months
hand-grip strength
Record the trajectory of hand-grip strength during cancer treatment using Hand-held dynamometer
5 months
pulmonary function
Record the trajectory of pulmonary function(FVC, FEV1) during cancer treatment using spirometry. The parameters are recorded with the prediction values of FVC% and FEV1%.
5 months
maximal inspiratory pressure
Record the trajectory of maximal inspiratory pressure during cancer treatment using inspiratory training device: POWERbreathe KH1
5 months
anxiety and depression (HADS questionnaire)
Record the trajectory of anxiety and depression during cancer treatment
5 months
quality of life (EORTC-QLQ-C30 questionnaire)
Record the trajectory of quality of life during cancer treatment
5 months
severity of symptom (QLQ-OES18 questionnaire)
Record the trajectory of severity of symptom during cancer treatment
5 months
Secondary Outcomes (6)
chemoradiotherapy-related toxicity (CTCAE grading system)
5 months
length of hospital stay
5 months
treatment interruptions
5 months
unplanned hospital admission
5 months
postoperative pulmonary complications
30 days
- +1 more secondary outcomes
Study Arms (2)
Walk, eat, & breathe group
EXPERIMENTALParticipants in the experimental group will receive "Walk, Eat, \& Breathe" at initiation of CCRT and ends before curative surgery.
Control group
NO INTERVENTIONParticipants in the control group received usual care.
Interventions
1. Walking exercise: 3 times per week, 20\~30 mins per section 2. Eat: nutritional assessment and advice weekly 3. Inspiratory muscle training: twice every day, 7 days a week, 6\~8 weeks before surgery
Eligibility Criteria
You may qualify if:
- the patient is cognitively capable to understand the trial;
- locally advanced tumors of the esophagus, defined as American Joint Committee on Cancer (AJCC) stage IIB or higher, were scheduled for neoadjuvant chemoradiotherapy and subsequent curative surgery;
- the patient is willing to sign the informed consent form.
You may not qualify if:
- age \<20 years;
- the patient is unable to communicate in the Chinese language; and
- the patient has contraindications that limit physical activity such as severe cardiac disease, recent myocardial infarction or uncontrolled hypertension.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 10048, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cheryl Chia-Hui Chen, PhD
National Taiwan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2016
First Posted
July 29, 2016
Study Start
May 1, 2016
Primary Completion
April 1, 2019
Study Completion
April 1, 2019
Last Updated
September 26, 2017
Record last verified: 2017-09